The prognosis after contraindicated surgery of NSCLC patients with malignant pleural effusion (M1a) may be better than expected

Although non-small cell lung cancer (NSCLC) with malignant pleural effusion (M1a) is generally contraindicated for surgery, several reports have demonstrated favorable prognosis. This study aimed to describe the results of surgical intervention in this disease. In this retrospective study, we evalua...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Yijiu, Dai, Chenyang, Shen, Jianfei, Liu, Yang, Xie, Dong, Zheng, Hui, He, Jiaxi, Liang, Wenhua, Jiang, Gening, Fei, Ke, Yang, Ping, He, Jianxing, Chen, Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042020/
https://www.ncbi.nlm.nih.gov/pubmed/27057627
http://dx.doi.org/10.18632/oncotarget.8566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042020/
https://www.ncbi.nlm.nih.gov/pubmed/27057627
http://dx.doi.org/10.18632/oncotarget.8566

Ejemplares similares